Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nilubol Raunroadroong"'
Autor:
Songporn Oranratnachai, Sasivimol Rattanasiri, Ekaphop Sirachainan, Amarit Tansawet, Nilubol Raunroadroong, Gareth J. McKay, John Attia, Ammarin Thakkinstian
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3046-3053 (2023)
Abstract Background Multikinase inhibitors (MKIs) represent the main treatment options for advanced hepatocellular carcinoma (aHCC). However, accessibility in developing countries is limited. A chemotherapy, Fluorouracil and Oxaliplatin (FOLFOX), off
Externí odkaz:
https://doaj.org/article/8d6555e6533343609bcc614e15de136d
Autor:
Songporn Oranratnachai, Sasivimol Rattanasiri, Ekaphop Sirachainan, Amarit Tansawet, Nilubol Raunroadroong, Gareth J. McKay, John Attia, Ammarin Thakkinstian
Publikováno v:
Oranratnachai, S, Rattanasiri, S, Sirachainan, E, Tansawet, A, Raunroadroong, N, McKay, G J, Attia, J & Thakkinstian, A 2022, ' Treatment outcomes of advanced hepatocellular carcinoma in real-life practice: Chemotherapy versus multikinase inhibitors ', Cancer Medicine . https://doi.org/10.1002/cam4.5224
BACKGROUND: Multikinase inhibitors (MKIs) represent the main treatment options for advanced hepatocellular carcinoma (aHCC). However, accessibility in developing countries is limited. A chemotherapy, Fluorouracil and Oxaliplatin (FOLFOX), offers a le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::884a16f4e68e21188251aff202b7f4b2
https://pure.qub.ac.uk/en/publications/9983cad8-b4e0-4ab8-87f2-3bf3c07963be
https://pure.qub.ac.uk/en/publications/9983cad8-b4e0-4ab8-87f2-3bf3c07963be
Autor:
Stig Larsen, Sirikul Sorrarichingchai, Isaraporn Sangsaikae, Henrik Harling, Kritiya Butthongkomvong, Nilubol Raunroadroong, Vichien Srimuninnimit
Publikováno v:
Butthongkomvong, K, Raunroadroong, N, Sorrarichingchai, S, Sangsaikae, I, Srimuninnimit, V, Harling, H & Larsen, S 2019, ' Efficacy and tolerability of BP-C1 in metastatic breast cancer : A Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study ', Breast Cancer: Targets and Therapy, vol. 11, pp. 43-51 . https://doi.org/10.2147/BCTT.S174298
Breast Cancer : Targets and Therapy
Breast Cancer : Targets and Therapy
Kritiya Butthongkomvong,1 Nilubol Raunroadroong,2 Sirikul Sorrarichingchai,2 Isaraporn Sangsaikae,3 Vichien Srimuninnimit,4 Henrik Harling,5 Stig Larsen6 1Udonthani Cancer Hospital, Udonthani, Thailand; 2Lampang Cancer Hospital, Lampang, Thailand; 3U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06d5fe1b9f9239855eb3e959c8480617
https://www.dovepress.com/efficacy-and-tolerability-of-bp-c1-in-metastatic-breast-cancer-a-phase-peer-reviewed-article-BCTT
https://www.dovepress.com/efficacy-and-tolerability-of-bp-c1-in-metastatic-breast-cancer-a-phase-peer-reviewed-article-BCTT
Autor:
Sumitra Thongprasert, Nilubol Raunroadroong, Hutcha Sriplung, Nirush Lertprasertsuke, Witthanee Na Chiangmai, Suwalee Pojchamarnwiputh, Worapon Sinsuwan
Publikováno v:
Hepatic Oncology. 1:377-386
SUMMARY Aim: Cholangiocarcinoma (CCA) is a common form of cancer in Thailand. The diagnosis of CCA by pathology is widely accepted. Unfortunately, tissue diagnosis of mass-forming intrahepatic cholangiocarcinoma is difficult to perform due to the ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ce90f2e730382b9032b64ca3853aeb
https://doi.org/10.2217/hep.14.19
https://doi.org/10.2217/hep.14.19